Skip to main content

Sirona Biochem Corp(SBM-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Sirona Biochem Corp down on Thursday (SBM)

AI-generated - The Globe and Mail - Thu Dec 7, 2023

Sirona Biochem Corp opened trading today at $0.08 and closed at $0.07. It traded at a low of $0.07 to a high of $0.08.

Shares dipped -12.50 percent from the previous day's close of $0.08.

During the day across North America, the TSX Composite closed -0.50% at 20274.21, the S&P 500 closed -0.39% at 4549.34, the Dow Jones Industrial Average closed -0.19% at 36054.43 and the Nasdaq Composite closed -0.58% at 14146.71.

Sirona Biochem Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker SBM.

A total of 98,128 shares was traded during the session, with total trades of 18. On average, Sirona Biochem Corp has traded 26,118 shares over 5 days and 55,830 year-to-date.

The TSX-V overall saw 3,047 price advancers against 2,159 declines and 116 unchanged.

During the prior 52 weeks, SBM.VN has traded as high as $0.21 (April 25,2023) and low as $0.07 (November 02,2023). Moreover, in the last 52 weeks, Sirona Biochem Corp's shares have shrunken -50.00%, while they have plummeted -39.13% year-to-date.

It announced a 0.12 dividend on December 07/06, with an December 27/06 ex-date and January 01/70 pay day.

Following today's trading, Sirona Biochem Corp has a market capitalization of $20.18 million on a float of 252,224 shares outstanding. Its annual EPS is $-0.01.

Sirona Biochem Corp is a None company headquartered in Vancouver, CAN.

Based on 0.00 analysts, Sirona Biochem Corp gets an average recommendation of "Strong Sell" according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe